The Effect of Vitamin D Sublingual Spray on Vitamin D3 Levels in the Blood Compared to Other Forms of Vitamin D3
NCT ID: NCT06142136
Last Updated: 2023-11-21
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
99 participants
INTERVENTIONAL
2021-03-28
2021-04-26
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Vitamin D3 sublingual sprayable microemulsion.
Total participants: 34 participants Duration: 30 days.
Vitamin D substitution with sublingual sprayable microemulsion.
Participants received sublingual sprayable microemulsion of vitamin D3 4000 IU daily for 30 days.
Vitamin D3 oil droplets.
Total participants: 33 participants Duration: 30 days.
Vitamin D substitution with oil droplets
Participants received oil droplets of vitamin D3 4000 IU daily for 30 days.
Vitamin D3 capsules.
Total participants: 32 participants Duration: 30 days.
Vitamin D substitution with capsules
Participants received capsules of vitamin D3 4000 IU daily for 30 days.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Vitamin D substitution with sublingual sprayable microemulsion.
Participants received sublingual sprayable microemulsion of vitamin D3 4000 IU daily for 30 days.
Vitamin D substitution with oil droplets
Participants received oil droplets of vitamin D3 4000 IU daily for 30 days.
Vitamin D substitution with capsules
Participants received capsules of vitamin D3 4000 IU daily for 30 days.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Patients with mental health problems.
* Vitamin D level ≥ 30 ng/ml.
* Pregnant women.
* Any other illness or condition that the researcher deemed may interfere with the results.
* Patients who refuse the studies.
18 Years
65 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Pauls Stradins Clinical University Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Valdis Pirags, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
Pauls Stradins Clinical University Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Pauls Stradins Clinical Univeristy Hospital
Riga, , Latvia
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
250321-6L
Identifier Type: -
Identifier Source: org_study_id